😎 Summer Sale Exclusive - Up to 50% off AI-powered stock picks by InvestingProCLAIM SALE

Gland Pharma Ltd (GLAD)

NSE
Currency in INR
Disclaimer
1,994.75
+4.15(+0.21%)
Closed

GLAD Comments

Next 3 year 5000
1933 today
5DMA IS ABOVE  919.10++DECIDE   YOURSELF
highly  oversold   ++may   touch 940...decide   yourself
tuesday is  d  day +++be  alert   ...decide   yourself
DOUBLE BOTTOM  PATTERN  WAS   SEEN +++BE  ALERT..   TGT 910.50
B.N. SAHU​it had formed WHITE HORSES +++TGT 910..MIM.....DECIDE YOURSELF+++HIGHLY OVERSOLD ...NO IF BUT
Should Hold Or Exit ?
lagta he 500 pe jayga
Another bull trap is loading before it slides below 1200. Don't fall for the false breakout.
Looks like 1400 is possible after Q3 results. Despite -60% wealth erosion in the past 12 months, it still looks overvalued for potential acquirers.
PE ratio is still quite high compared to similar pharma companies. This should go under 1600 soon.
what is the target now
The firm told analysts that it aims to sell as much as $11 billion worth of non-core assets within the next 12 months. The assets it considers core include pharmaceutical, retail, tourism and insurance interests.
what is the target now ?
Two more bad quarters expected. This will probably be removed from Nifty Next 50 in March.
2600+ soon on card
Beware of this stock anytime it can come down…
loser like u beware we are not stop trading
Where you?
Some big investor are making the market down ..
this stock hit today 52 weeks high value
hi
listing price would be 1700++
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.